D T Aftab

Summary

Affiliation: Exelixis Inc
Country: USA

Publications

  1. ncbi MET and VEGF: synergistic targets in castration-resistant prostate cancer
    D T Aftab
    Exelixis, Inc, South San Francisco, CA 94083 0511, USA
    Clin Transl Oncol 13:703-9. 2011

Detail Information

Publications1

  1. ncbi MET and VEGF: synergistic targets in castration-resistant prostate cancer
    D T Aftab
    Exelixis, Inc, South San Francisco, CA 94083 0511, USA
    Clin Transl Oncol 13:703-9. 2011
    ..Inhibition of both the MET and VEGF pathways may improve the efficacy of angiogenesis inhibitors in prostate cancer...